FDA Issues Emergency Use Authorization For Rapid Antigen Test For SARS-CoV-2

Infectious Disease Advisor (9/1, Park) reports the FDA issued an emergency use authorization for Abbott’s BinaxNOW COVID-19 Ag Card, a rapid antigen test for SARS-CoV-2. The test “is an assay for the qualitative detection of nucleocapsid protein antigen f...